Azotemia

A biochemical abnormality referring to an elevation of BLOOD UREA NITROGEN and CREATININE. Azotemia can be produced by KIDNEY DISEASES or other extrarenal disorders. When azotemia becomes associated with a constellation of clinical signs, it is termed UREMIA.

Organizations

Organization Involved with Phase 4 Indications (2)

Hospital General de Niños Pedro de Elizalde
University of Nantes

Organization Involved with Phase 3 Indications (3)

Alexion
Omeros Corporation
University of Toulouse

Organization Involved with Phase 2 Indications (11)

Roche
Alnylam Pharmaceuticals
ChemoCentryx
Hamilton Health Sciences Corporation
McMaster University
University of Toronto
University of Cincinnati
Mario Negri Institute
Vita-Salute University of Milano. Italy
Canadian Apheresis Group
University of Western Ontario

Organization Involved with Other Experimental Indications (1)

University of Paris